🔗 Permalink

Inventor profile of:

Bernard Maillere

City:

Versailles

Country:

France

Published Applications:

Last publication date:

2023-05-11

Top Assignees for applications by Bernard Maillere

The entities that hold a legal rights for patent applications filed by inventor Maillere Bernard:

Commissariat A L'Energie Atomique Et Aux Energies Alternatives 5 Paris, France
Commissariat A L'Energie Atomique 5 Paris, France
Institut National De La Sante Et De La Recherche Medicale (INSERM) 2 Paris, France
SEDAC THERAPEUTICS 2 Loos, France
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE 1 PARIS, France
COMMISSARIAT A L'ENERGIE ATOMIQUE ET AUX ENE ALT 1 Paris, France
Institut National de la Sante et de la Recherche Medicale 1 Paris, France
Commissariat a I'Energie Atomique 1 Paris, France
COMMISSARIANT A L'ENERGIE ATOMIQUE ET AUX ENERGIES ALTERNATIVES 1 Paris, France

Recent patent applications by Maillere Bernard

Bernard Maillere from Versailles, FR has applied for patents for these inventions. The list has both pending applications and granted patents:

#1 | 2023-05-11

US20230142800A1

Chemistry; metallurgy

Adalimumab Variants with Reduced Immunogenic Potential

#2 | 2018-03-29

US20180086804A1

Chemistry; metallurgy

Immunogenic peptides of the cyclin B1 tumor antigen

#3 | 2016-09-08

US20160257727A1

Chemistry; metallurgy

IMMUNOGENIC PEPTIDES OF THE CYCLIN B1 TUMOR ANTIGEN

#4 | 2015-02-19

US20150051146A1

Chemistry; metallurgy

HB-EGF inhibitor derived from the R domain of diphtheria toxin for the treatment of diseases associated with the activation of the HB-EGF/EGFR pathway

#5 | 2015-02-19

US20150050304A1

Human necessities

CD4+ T survivin epitopes and uses thereof

#6 | 2013-05-30

US20130137085A1

Physics

Method for real-time measurement of the individual secretions of a cell

#7 | 2011-11-10

US20110275098A1

Physics

Method for Evaluating The Immunogenicity of Proteins

#8 | 2011-06-30

US20110159022A1

Human necessities

Immunogenic Peptides Derived from the Midkine Protein, as an Anticancer Vaccine

#9 | 2010-12-23

US20100324829A1

Physics

METHOD OF SELECTING HLA-DP4 LIGANDS AND THE APPLICATIONS THEREOF

#10 | 2010-08-12

US20100203080A1

Chemistry; metallurgy

Mixture of Peptides Derived from E6 and/or E7 Papillomavirus Proteins and Uses Thereof

#11 | 2009-05-21

US20090130134A1

Chemistry; metallurgy

T CD4+ Epitopes of Type I and II Latency Antigens of the Epstein-Barr Virus, Which Can Be Recognized by the majority of individuals in the caucasian populations and applications thereof

#12 | 2009-02-10

US10476570

Mixture of peptides derived from E6 and/or E7 papillomavirus proteins and uses thereof

#13 | 2009-01-01

US20090004214A1

Human necessities

Cd4+ Survivin Epitopes and Uses Thereof

#14 | 2006-05-25

US20060110401A1

Chemistry; metallurgy

Mixture of peptides from c and ns3 proteins of the hepatitis c virus and applications thereof

#15 | 2005-03-17

US20050059107A1

Physics

Method of selecting HLA-DP4 ligands and the applications thereof

InventorID:

1072243 ⎘